Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction
about
sameAs
Immunization with a mimotope of GD2 ganglioside induces CD8+ T cells that recognize cell adhesion molecules on tumor cellsActivated leukocyte cell adhesion molecule in breast cancer: prognostic indicatorCell Adhesion Molecules and Ubiquitination-Functions and SignificanceLesser-Known Molecules in Ovarian CarcinogenesisDepending on its nano-spacing, ALCAM promotes cell attachment and axon growthMolecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell functionThe adhesion molecule Necl-3/SynCAM-2 localizes to myelinated axons, binds to oligodendrocytes and promotes cell adhesionA novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth.Syntenin-1 and ezrin proteins link activated leukocyte cell adhesion molecule to the actin cytoskeletonA genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors.ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to boneRelevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients.ALCAM regulates motility, invasiveness, and adherens junction formation in uveal melanoma cells.Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cellsPrognostic value of CD166 expression in cancers of the digestive system: a systematic review and meta-analysis.NF-kappaB P50/P65 hetero-dimer mediates differential regulation of CD166/ALCAM expression via interaction with micoRNA-9 after serum deprivation, providing evidence for a novel negative auto-regulatory loop.ALCAM: Basis Sequence: MouseStructures of CD6 and Its Ligand CD166 Give Insight into Their Interaction.Expression and Role of CD166 in the Chronic Kidney Disease.Expression and regulation of activated leukocyte cell adhesion molecule in human retinal vascular endothelial cells.Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS.Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer.Adhesion molecules in endometrial epithelium: tissue integrity and embryo implantation.Dual role of ALCAM in neuroinflammation and blood-brain barrier homeostasis.Cluster of differentiation 166 (CD166) regulated by phosphatidylinositide 3-Kinase (PI3K)/AKT signaling to exert its anti-apoptotic role via yes-associated protein (YAP) in liver cancer.Review: leucocyte-endothelial cell crosstalk at the blood-brain barrier: a prerequisite for successful immune cell entry to the brain.Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors.ALCAM/CD166 adhesive function is regulated by the tetraspanin CD9.A systematic evaluation for the potential translation of CD166-related expression as a cancer biomarker.Mechanisms of transcriptional regulation and prognostic significance of activated leukocyte cell adhesion molecule in cancer.Ubiquitination and endocytosis of cell adhesion molecule DM-GRASP regulate its cell surface presence and affect its role for axon navigation.Serum CD166: A novel biomarker for predicting nasopharyngeal carcinoma response to radiotherapy.Clinicopathological, prognostic and predictive value of CD166 expression in colorectal cancer: a meta-analysis.Functional polymorphisms in CD166/ALCAM gene associated with increased risk for breast cancer in a Chinese population.Key Factors in Breast Cancer Dissemination and Establishment at the Bone: Past, Present and Future Perspectives.Cell Adhesion Molecule CD166 Drives Malignant Progression and Osteolytic Disease in Multiple Myeloma.Prognostic Significance of Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Association with Promoter Methylation of the ALCAM Gene in Breast Cancer.ALCAM (CD166) is involved in extravasation of monocytes rather than T cells across the blood-brain barrier.ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer.Cancer stem cells biomarkers in gastric carcinogenesis.
P2860
Q24648424-603B9846-DC31-4785-B8D2-6E7E6DF046E0Q24806155-664D3C4E-7EC4-4948-86D0-590BF0B5F912Q26771983-2793F09A-739F-4435-9A39-A101D7DB74ABQ26784533-52243479-E1AA-4A26-9367-D9CAB74934DEQ27334761-A383F8E0-0107-46A7-B881-A7D1BF2BA4AFQ28288857-1FF4551B-7B48-4376-8AAC-A418DAB90953Q28568350-1F188BAF-754A-4CF8-96AC-59888556BA4DQ33634142-34203903-69B4-4FA0-9CCB-A4CB7D9BF798Q33676712-3CBBD6E1-8A96-4FA6-90A7-E0B8A2310F69Q33906477-B0CD40A5-6F53-4B66-8AB7-00869ED829A5Q34112011-C9516E69-F0A1-4196-9523-00FB6FFA6B4CQ34220083-484E7CED-B460-4158-BA4F-C800DE45CC85Q34321331-849023A1-494C-448C-B373-DD4CCCFE8C13Q34374335-46B38DC5-6C54-4012-AB54-B34449FDF92AQ34936453-13575D5A-3B6B-453D-B73C-3B32F31436D6Q35174757-DE4289A4-444A-4E1C-9BEB-58F69FEBAD65Q35609716-5251B142-A475-43DD-B6AD-88CAD78B7B8CQ35943010-854BA330-5504-4BF6-8851-214FB9D7F6CEQ36175628-55354D72-8493-480B-B872-BE8A6BDEE152Q36566608-EBCFB0B3-8A00-4118-B654-515E95E01B9FQ36775309-0D8998AE-42A3-4F6C-A79A-4F6A4E0E4457Q37095851-E4EDE3F8-7DCC-49E1-9A84-454E27939F38Q37488290-D86B88C3-09A6-4F4B-9590-55EC865AEF1EQ37612597-35062719-3CCB-4094-858E-226B3812BA35Q37622617-8F3F0777-E476-45DC-8816-5CD34CBD42D4Q37800163-D189816C-C8E6-452D-ABF4-A5BAF6AB04FDQ39241466-4FC217DA-9368-44DA-A396-A16D3A1EA06BQ39262727-33783BEB-A781-4128-9C94-99B0A3A9A7D8Q39615435-6E115B5F-2ECD-424A-B6AD-5B394D9B6AF1Q39647270-6A569A97-9FA6-4697-97C9-022462504EBBQ39940191-4D18A028-8E10-442E-867F-DCEC881F248EQ42362640-DDEB26F0-BC6B-495F-A4EE-DF742B2A0824Q42362789-9B8AA342-3A4E-4807-A849-B92C219E0B07Q44863079-70120744-B7CF-4DD4-83FF-EEA099F2590BQ47250561-65A2F3D0-ED0A-499F-9F53-197635444161Q48041020-6A30370D-FB4E-4448-8D7C-EC1E43FED242Q48284336-FA3A1E42-7D66-444A-9AD9-463E407552A8Q49080862-E3F9590E-F9A7-4A82-A614-FB8573547969Q52571266-749229AD-8424-4E9A-9C81-602D6AA3BA24Q53250527-9BC5E8B4-B54C-4A49-AE5D-100FBA583F49
P2860
Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Molecular basis for the homoph ...... cule (ALCAM)-ALCAM interaction
@ast
Molecular basis for the homoph ...... cule (ALCAM)-ALCAM interaction
@en
Molecular basis for the homoph ...... cule (ALCAM)-ALCAM interaction
@nl
type
label
Molecular basis for the homoph ...... cule (ALCAM)-ALCAM interaction
@ast
Molecular basis for the homoph ...... cule (ALCAM)-ALCAM interaction
@en
Molecular basis for the homoph ...... cule (ALCAM)-ALCAM interaction
@nl
prefLabel
Molecular basis for the homoph ...... cule (ALCAM)-ALCAM interaction
@ast
Molecular basis for the homoph ...... cule (ALCAM)-ALCAM interaction
@en
Molecular basis for the homoph ...... cule (ALCAM)-ALCAM interaction
@nl
P2093
P2860
P356
P1476
Molecular basis for the homoph ...... cule (ALCAM)-ALCAM interaction
@en
P2093
Bloemers HP
Nelissen JM
Torensma R
van Kempen LC
P2860
P304
25783-25790
P356
10.1074/JBC.M011272200
P407
P50
P577
2001-04-16T00:00:00Z